Figure 2.

Prescription prevalence of other drugs in children and adolescents with MS compared with the controls (2018). In this diagram, the prescription prevalence of ATC therapeutic subgroups of 613 pediatric PwMS (bars: blue—MS, orange—controls) and the prescription mean values per patient with a respective prescription (dots: blue—MS, orange—controls) compared with the matched controls (n = 6130) are presented. Vitamins (A11: 23.2%), drugs for acid-related diseases (A02: 18.3%), and hormone therapy (G03: 17.0%) were prescribed most frequently among MS patients. There were significantly more prescriptions of vitamins and drugs for acid-related diseases for pediatric PwMS compared with the controls (FDR: q < 0.001). The largest average prescription value per MS patient with a respective prescription was found for hormone therapy (3.1). ATC: Anatomical Therapeutic Chemical codes; FDR: false discovery rate; MS: multiple sclerosis; q: p value adjustment according to FDR; PwMS: patients with multiple sclerosis.